STRATA Skin Sciences, Inc. is a medical technology company in Dermatology and Plastic Surgery. The company is headquartered in Horsham, Pennsylvania and currently employs 106 full-time employees. The company went IPO on 2005-10-28. The firm is engaged in developing, commercializing and marketing products for the treatment of dermatologic conditions. The firm operates through two segments: Dermatology Recurring Procedures and Dermatology Procedures Equipment. The Company’s products include the XTRAC and Pharos excimer lasers and VTRAC lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions. Its products also include the TheraClear Acne Therapy System utilized in the treatment of mild to moderate inflammatory, comedonal and pustular acne. The XTRAC and Pharos excimer laser technology emits highly concentrated ultraviolet (UV) light targeted primarily towards autoimmune dermatological skin disorders, such as psoriasis, vitiligo, atopic dermatitis, and eczema, among others. VTRAC is a UV light lamp system that works in much the same way as the XTRAC.
Dr. Dolev Rafaeli est le President de Strata Skin Sciences Inc, il a rejoint l'entreprise depuis 2018.
Quelle est la performance du prix de l'action SSKN ?
Le prix actuel de SSKN est de $0.122, il a diminué de 0% lors de la dernière journée de trading.
Quels sont les thèmes d'affaires principaux ou les industries de Strata Skin Sciences Inc ?
Strata Skin Sciences Inc appartient à l'industrie Health Care et le secteur est Health Care
Quel est la capitalisation boursière de Strata Skin Sciences Inc ?
La capitalisation boursière actuelle de Strata Skin Sciences Inc est de $718.5K
Est-ce que Strata Skin Sciences Inc est un achat, une vente ou un maintien ?
Selon les analystes de Wall Street, 4 analystes ont établi des notations d'analystes pour Strata Skin Sciences Inc, y compris 3 achat fort, 4 achat, 1 maintien, 0 vente et 3 vente forte